Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
117 |
1805 |
1.153e-29 |
2.682e-26 |
2 |
RESPONSE TO ENDOGENOUS STIMULUS |
104 |
1450 |
1.038e-29 |
2.682e-26 |
3 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
115 |
1784 |
6.778e-29 |
1.051e-25 |
4 |
CELL CYCLE |
96 |
1316 |
7.405e-28 |
6.891e-25 |
5 |
REGULATION OF CELL PROLIFERATION |
103 |
1496 |
5.966e-28 |
6.891e-25 |
6 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
101 |
1517 |
3.196e-26 |
2.479e-23 |
7 |
REGULATION OF CELL DEATH |
99 |
1472 |
5.202e-26 |
3.458e-23 |
8 |
REGULATION OF CELL CYCLE |
78 |
949 |
9.344e-26 |
5.435e-23 |
9 |
REGULATION OF BINDING |
44 |
283 |
1.33e-25 |
6.877e-23 |
10 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
86 |
1152 |
1.565e-25 |
7.284e-23 |
11 |
NEGATIVE REGULATION OF GENE EXPRESSION |
98 |
1493 |
6.25e-25 |
2.644e-22 |
12 |
PEPTIDYL AMINO ACID MODIFICATION |
71 |
841 |
4.179e-24 |
1.62e-21 |
13 |
CELL CYCLE PROCESS |
80 |
1081 |
1.824e-23 |
6.53e-21 |
14 |
RESPONSE TO HORMONE |
72 |
893 |
2.93e-23 |
9.197e-21 |
15 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
73 |
917 |
2.965e-23 |
9.197e-21 |
16 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
107 |
1848 |
5.736e-23 |
1.668e-20 |
17 |
POSITIVE REGULATION OF GENE EXPRESSION |
103 |
1733 |
6.49e-23 |
1.749e-20 |
18 |
MITOTIC CELL CYCLE |
66 |
766 |
6.765e-23 |
1.749e-20 |
19 |
CELLULAR RESPONSE TO STRESS |
97 |
1565 |
8.008e-23 |
1.961e-20 |
20 |
REGULATION OF ORGANELLE ORGANIZATION |
82 |
1178 |
2.428e-22 |
5.649e-20 |
21 |
RESPONSE TO LIPID |
70 |
888 |
4.71e-22 |
1.044e-19 |
22 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
100 |
1710 |
1.089e-21 |
2.304e-19 |
23 |
RESPONSE TO STEROID HORMONE |
50 |
497 |
2.535e-20 |
5.128e-18 |
24 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
86 |
1381 |
2.824e-20 |
5.476e-18 |
25 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
72 |
1008 |
3.184e-20 |
5.925e-18 |
26 |
CELL PROLIFERATION |
57 |
672 |
1.683e-19 |
3.012e-17 |
27 |
REGULATION OF CELL DIFFERENTIATION |
88 |
1492 |
3.167e-19 |
5.459e-17 |
28 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
52 |
573 |
4.069e-19 |
6.762e-17 |
29 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
75 |
1142 |
5.901e-19 |
9.468e-17 |
30 |
POSITIVE REGULATION OF CELL PROLIFERATION |
62 |
814 |
8.152e-19 |
1.264e-16 |
31 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
91 |
1618 |
1.526e-18 |
2.291e-16 |
32 |
CHROMOSOME ORGANIZATION |
69 |
1009 |
2.257e-18 |
3.281e-16 |
33 |
REGULATION OF MITOTIC CELL CYCLE |
46 |
468 |
2.333e-18 |
3.289e-16 |
34 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
86 |
1492 |
3.714e-18 |
5.082e-16 |
35 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
92 |
1672 |
3.936e-18 |
5.233e-16 |
36 |
NEGATIVE REGULATION OF CELL DEATH |
63 |
872 |
5.716e-18 |
7.388e-16 |
37 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
68 |
1004 |
6.83e-18 |
8.589e-16 |
38 |
CHROMATIN ORGANIZATION |
54 |
663 |
1.002e-17 |
1.227e-15 |
39 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
56 |
720 |
1.88e-17 |
2.243e-15 |
40 |
CHROMATIN MODIFICATION |
48 |
539 |
2.246e-17 |
2.549e-15 |
41 |
NEGATIVE REGULATION OF CELL CYCLE |
43 |
433 |
2.192e-17 |
2.549e-15 |
42 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
94 |
1791 |
3.428e-17 |
3.797e-15 |
43 |
RESPONSE TO ALCOHOL |
39 |
362 |
4.611e-17 |
4.99e-15 |
44 |
CELL CYCLE PHASE TRANSITION |
33 |
255 |
5.664e-17 |
5.99e-15 |
45 |
REGULATION OF CELL CYCLE PROCESS |
48 |
558 |
8.947e-17 |
9.251e-15 |
46 |
CELL CYCLE CHECKPOINT |
29 |
194 |
9.261e-17 |
9.368e-15 |
47 |
DNA METABOLIC PROCESS |
56 |
758 |
1.852e-16 |
1.833e-14 |
48 |
PROTEIN PHOSPHORYLATION |
63 |
944 |
2.69e-16 |
2.594e-14 |
49 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
55 |
740 |
2.731e-16 |
2.594e-14 |
50 |
COVALENT CHROMATIN MODIFICATION |
37 |
345 |
3.539e-16 |
3.293e-14 |
51 |
PHOSPHORYLATION |
73 |
1228 |
4.134e-16 |
3.772e-14 |
52 |
POSITIVE REGULATION OF CELL DEATH |
49 |
605 |
4.668e-16 |
4.177e-14 |
53 |
POSITIVE REGULATION OF CELL CYCLE |
36 |
332 |
6.383e-16 |
5.604e-14 |
54 |
REPRODUCTION |
75 |
1297 |
6.723e-16 |
5.793e-14 |
55 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
52 |
691 |
1.158e-15 |
9.796e-14 |
56 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
28 |
199 |
1.58e-15 |
1.313e-13 |
57 |
REGULATION OF RESPONSE TO STRESS |
80 |
1468 |
1.688e-15 |
1.378e-13 |
58 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
66 |
1079 |
3.426e-15 |
2.745e-13 |
59 |
RESPONSE TO ABIOTIC STIMULUS |
64 |
1024 |
3.48e-15 |
2.745e-13 |
60 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
50 |
662 |
3.736e-15 |
2.85e-13 |
61 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
50 |
662 |
3.736e-15 |
2.85e-13 |
62 |
NEGATIVE REGULATION OF BINDING |
23 |
131 |
4.158e-15 |
3.12e-13 |
63 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
66 |
1087 |
4.888e-15 |
3.591e-13 |
64 |
GLAND DEVELOPMENT |
38 |
395 |
4.939e-15 |
3.591e-13 |
65 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
93 |
1929 |
1.065e-14 |
7.626e-13 |
66 |
REGULATION OF PROTEIN BINDING |
25 |
168 |
1.426e-14 |
1.005e-12 |
67 |
REGULATION OF TRANSFERASE ACTIVITY |
60 |
946 |
1.489e-14 |
1.034e-12 |
68 |
MITOTIC CELL CYCLE CHECKPOINT |
23 |
139 |
1.58e-14 |
1.081e-12 |
69 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
47 |
616 |
1.842e-14 |
1.242e-12 |
70 |
CELLULAR RESPONSE TO LIPID |
40 |
457 |
2.18e-14 |
1.429e-12 |
71 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
48 |
643 |
2.169e-14 |
1.429e-12 |
72 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
55 |
823 |
2.486e-14 |
1.607e-12 |
73 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
75 |
1395 |
3.103e-14 |
1.978e-12 |
74 |
CELL DEVELOPMENT |
76 |
1426 |
3.184e-14 |
2.002e-12 |
75 |
REGULATION OF CELLULAR LOCALIZATION |
71 |
1277 |
3.29e-14 |
2.041e-12 |
76 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
66 |
1135 |
3.81e-14 |
2.332e-12 |
77 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
40 |
465 |
3.869e-14 |
2.338e-12 |
78 |
REGULATION OF DNA METABOLIC PROCESS |
34 |
340 |
4.662e-14 |
2.777e-12 |
79 |
DNA INTEGRITY CHECKPOINT |
23 |
146 |
4.715e-14 |
2.777e-12 |
80 |
POSITIVE REGULATION OF CELL COMMUNICATION |
79 |
1532 |
5.22e-14 |
3.036e-12 |
81 |
AGING |
30 |
264 |
5.293e-14 |
3.041e-12 |
82 |
ORGAN MORPHOGENESIS |
55 |
841 |
6.077e-14 |
3.449e-12 |
83 |
NEUROGENESIS |
74 |
1402 |
1.21e-13 |
6.782e-12 |
84 |
INTRACELLULAR SIGNAL TRANSDUCTION |
79 |
1572 |
2.034e-13 |
1.127e-11 |
85 |
EMBRYO DEVELOPMENT |
56 |
894 |
2.091e-13 |
1.145e-11 |
86 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
34 |
363 |
3.111e-13 |
1.683e-11 |
87 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
81 |
1656 |
3.974e-13 |
2.113e-11 |
88 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
28 |
247 |
3.997e-13 |
2.113e-11 |
89 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
26 |
214 |
5.585e-13 |
2.92e-11 |
90 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
26 |
218 |
8.628e-13 |
4.461e-11 |
91 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
36 |
422 |
9.966e-13 |
5.096e-11 |
92 |
REGULATION OF CELL CYCLE ARREST |
19 |
108 |
1.008e-12 |
5.099e-11 |
93 |
REGULATION OF CHROMOSOME ORGANIZATION |
29 |
278 |
1.256e-12 |
6.282e-11 |
94 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
51 |
799 |
1.372e-12 |
6.789e-11 |
95 |
RESPONSE TO NITROGEN COMPOUND |
53 |
859 |
1.777e-12 |
8.704e-11 |
96 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
89 |
1977 |
2.262e-12 |
1.096e-10 |
97 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
41 |
552 |
2.295e-12 |
1.101e-10 |
98 |
MITOTIC DNA INTEGRITY CHECKPOINT |
18 |
100 |
2.674e-12 |
1.269e-10 |
99 |
CELL DIVISION |
37 |
460 |
2.782e-12 |
1.308e-10 |
100 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
46 |
689 |
4.087e-12 |
1.901e-10 |
101 |
NEGATIVE REGULATION OF PROTEIN BINDING |
16 |
79 |
6.691e-12 |
3.082e-10 |
102 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
21 |
152 |
8.259e-12 |
3.768e-10 |
103 |
REGULATION OF DNA BINDING |
17 |
93 |
8.399e-12 |
3.794e-10 |
104 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
30 |
321 |
8.57e-12 |
3.834e-10 |
105 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
52 |
872 |
1.055e-11 |
4.676e-10 |
106 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
45 |
684 |
1.169e-11 |
5.132e-10 |
107 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
68 |
1360 |
1.654e-11 |
7.191e-10 |
108 |
REGULATION OF KINASE ACTIVITY |
48 |
776 |
2.006e-11 |
8.525e-10 |
109 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
39 |
541 |
2.015e-11 |
8.525e-10 |
110 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
39 |
541 |
2.015e-11 |
8.525e-10 |
111 |
REGULATION OF CELL DIVISION |
27 |
272 |
2.435e-11 |
1.021e-09 |
112 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
55 |
983 |
2.948e-11 |
1.225e-09 |
113 |
RESPONSE TO GROWTH FACTOR |
36 |
475 |
3.057e-11 |
1.249e-09 |
114 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
20 |
146 |
3.06e-11 |
1.249e-09 |
115 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
41 |
602 |
3.533e-11 |
1.429e-09 |
116 |
SKELETAL SYSTEM DEVELOPMENT |
35 |
455 |
3.865e-11 |
1.528e-09 |
117 |
RESPONSE TO INORGANIC SUBSTANCE |
36 |
479 |
3.875e-11 |
1.528e-09 |
118 |
RHYTHMIC PROCESS |
28 |
298 |
3.815e-11 |
1.528e-09 |
119 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
22 |
185 |
5.376e-11 |
2.102e-09 |
120 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
56 |
1036 |
7.178e-11 |
2.76e-09 |
121 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
56 |
1036 |
7.178e-11 |
2.76e-09 |
122 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
45 |
724 |
7.679e-11 |
2.929e-09 |
123 |
REGULATION OF PROTEIN LOCALIZATION |
53 |
950 |
7.818e-11 |
2.957e-09 |
124 |
CELL CYCLE G2 M PHASE TRANSITION |
19 |
138 |
8.768e-11 |
3.29e-09 |
125 |
REGULATION OF HOMEOSTATIC PROCESS |
34 |
447 |
1.006e-10 |
3.746e-09 |
126 |
RESPONSE TO OXYGEN LEVELS |
28 |
311 |
1.04e-10 |
3.839e-09 |
127 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
71 |
1518 |
1.135e-10 |
4.158e-09 |
128 |
REGULATION OF FIBROBLAST PROLIFERATION |
15 |
81 |
1.183e-10 |
4.3e-09 |
129 |
RESPONSE TO EXTERNAL STIMULUS |
80 |
1821 |
1.267e-10 |
4.571e-09 |
130 |
TUBE DEVELOPMENT |
38 |
552 |
1.414e-10 |
5.062e-09 |
131 |
MITOTIC NUCLEAR DIVISION |
30 |
361 |
1.582e-10 |
5.619e-09 |
132 |
RESPONSE TO DRUG |
33 |
431 |
1.616e-10 |
5.696e-09 |
133 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
32 |
408 |
1.68e-10 |
5.879e-09 |
134 |
ORGAN REGENERATION |
15 |
83 |
1.701e-10 |
5.906e-09 |
135 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
15 |
85 |
2.42e-10 |
8.341e-09 |
136 |
TUBE MORPHOGENESIS |
28 |
323 |
2.5e-10 |
8.555e-09 |
137 |
REGULATION OF CELL DEVELOPMENT |
48 |
836 |
2.563e-10 |
8.706e-09 |
138 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
40 |
616 |
2.588e-10 |
8.726e-09 |
139 |
RESPONSE TO KETONE |
21 |
182 |
2.615e-10 |
8.753e-09 |
140 |
PEPTIDYL SERINE MODIFICATION |
19 |
148 |
2.997e-10 |
9.961e-09 |
141 |
EPITHELIUM DEVELOPMENT |
51 |
945 |
5.878e-10 |
1.94e-08 |
142 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
59 |
1192 |
6.525e-10 |
2.138e-08 |
143 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
49 |
891 |
7.057e-10 |
2.296e-08 |
144 |
TISSUE MORPHOGENESIS |
36 |
533 |
7.427e-10 |
2.383e-08 |
145 |
TISSUE DEVELOPMENT |
69 |
1518 |
7.398e-10 |
2.383e-08 |
146 |
RESPONSE TO CORTICOSTEROID |
20 |
176 |
9.201e-10 |
2.932e-08 |
147 |
CELL AGING |
13 |
67 |
1.132e-09 |
3.583e-08 |
148 |
RESPONSE TO ESTROGEN |
22 |
218 |
1.294e-09 |
4.068e-08 |
149 |
POSITIVE REGULATION OF BINDING |
17 |
127 |
1.354e-09 |
4.229e-08 |
150 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
15 |
96 |
1.427e-09 |
4.426e-08 |
151 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
33 |
470 |
1.485e-09 |
4.577e-08 |
152 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
18 |
145 |
1.535e-09 |
4.7e-08 |
153 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
36 |
552 |
1.901e-09 |
5.782e-08 |
154 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
15 |
98 |
1.918e-09 |
5.797e-08 |
155 |
DNA REPAIR |
33 |
480 |
2.517e-09 |
7.557e-08 |
156 |
PEPTIDYL LYSINE MODIFICATION |
26 |
312 |
2.565e-09 |
7.651e-08 |
157 |
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION |
18 |
150 |
2.668e-09 |
7.858e-08 |
158 |
CHROMATIN REMODELING |
18 |
150 |
2.668e-09 |
7.858e-08 |
159 |
REGULATION OF TRANSPORT |
76 |
1804 |
2.686e-09 |
7.86e-08 |
160 |
G1 DNA DAMAGE CHECKPOINT |
13 |
73 |
3.435e-09 |
9.989e-08 |
161 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
19 |
171 |
3.551e-09 |
1.026e-07 |
162 |
REGULATION OF CATABOLIC PROCESS |
42 |
731 |
3.607e-09 |
1.036e-07 |
163 |
CELL DEATH |
51 |
1001 |
4.147e-09 |
1.184e-07 |
164 |
BONE DEVELOPMENT |
18 |
156 |
5.028e-09 |
1.418e-07 |
165 |
MULTICELLULAR ORGANISM REPRODUCTION |
43 |
768 |
5.006e-09 |
1.418e-07 |
166 |
ORGANELLE FISSION |
33 |
496 |
5.673e-09 |
1.586e-07 |
167 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
67 |
1527 |
5.694e-09 |
1.586e-07 |
168 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
44 |
801 |
5.816e-09 |
1.611e-07 |
169 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
20 |
196 |
6.074e-09 |
1.672e-07 |
170 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
33 |
498 |
6.262e-09 |
1.714e-07 |
171 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
49 |
957 |
7.352e-09 |
2.001e-07 |
172 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
42 |
750 |
7.607e-09 |
2.058e-07 |
173 |
REGENERATION |
18 |
161 |
8.331e-09 |
2.241e-07 |
174 |
REGULATION OF NUCLEAR DIVISION |
18 |
163 |
1.014e-08 |
2.692e-07 |
175 |
FOREBRAIN DEVELOPMENT |
27 |
357 |
1.018e-08 |
2.692e-07 |
176 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
16 |
127 |
1.012e-08 |
2.692e-07 |
177 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
46 |
876 |
1.027e-08 |
2.701e-07 |
178 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
11 |
53 |
1.035e-08 |
2.706e-07 |
179 |
RESPONSE TO WOUNDING |
35 |
563 |
1.099e-08 |
2.857e-07 |
180 |
RESPONSE TO ESTRADIOL |
17 |
146 |
1.172e-08 |
3.03e-07 |
181 |
POSITIVE REGULATION OF DNA BINDING |
10 |
42 |
1.183e-08 |
3.042e-07 |
182 |
EMBRYONIC MORPHOGENESIS |
34 |
539 |
1.254e-08 |
3.207e-07 |
183 |
REGULATION OF INTRACELLULAR TRANSPORT |
37 |
621 |
1.263e-08 |
3.212e-07 |
184 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
17 |
147 |
1.301e-08 |
3.289e-07 |
185 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
28 |
387 |
1.416e-08 |
3.562e-07 |
186 |
HEAD DEVELOPMENT |
40 |
709 |
1.444e-08 |
3.612e-07 |
187 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
18 |
167 |
1.489e-08 |
3.704e-07 |
188 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
16 |
131 |
1.589e-08 |
3.933e-07 |
189 |
REGULATION OF GENE EXPRESSION EPIGENETIC |
21 |
229 |
1.702e-08 |
4.19e-07 |
190 |
RESPONSE TO EXTRACELLULAR STIMULUS |
30 |
441 |
1.739e-08 |
4.258e-07 |
191 |
RNA PROCESSING |
44 |
835 |
1.991e-08 |
4.851e-07 |
192 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
27 |
370 |
2.16e-08 |
5.208e-07 |
193 |
REGULATION OF CHROMATIN ORGANIZATION |
17 |
152 |
2.157e-08 |
5.208e-07 |
194 |
RESPONSE TO NUTRIENT |
19 |
191 |
2.215e-08 |
5.312e-07 |
195 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
13 |
85 |
2.343e-08 |
5.59e-07 |
196 |
PROTEIN AUTOPHOSPHORYLATION |
19 |
192 |
2.411e-08 |
5.725e-07 |
197 |
HISTONE PHOSPHORYLATION |
8 |
25 |
2.748e-08 |
6.49e-07 |
198 |
POSITIVE REGULATION OF TRANSPORT |
47 |
936 |
2.779e-08 |
6.531e-07 |
199 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
26 |
351 |
2.929e-08 |
6.848e-07 |
200 |
REGULATION OF MITOCHONDRION ORGANIZATION |
20 |
218 |
3.712e-08 |
8.635e-07 |
201 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
9 |
36 |
4.07e-08 |
9.422e-07 |
202 |
REGULATION OF ORGAN MORPHOGENESIS |
21 |
242 |
4.455e-08 |
1.026e-06 |
203 |
ENDOCRINE SYSTEM DEVELOPMENT |
15 |
123 |
4.571e-08 |
1.048e-06 |
204 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
32 |
514 |
4.638e-08 |
1.058e-06 |
205 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
26 |
360 |
4.875e-08 |
1.107e-06 |
206 |
APOPTOTIC SIGNALING PATHWAY |
23 |
289 |
5.071e-08 |
1.145e-06 |
207 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
29 |
437 |
5.185e-08 |
1.166e-06 |
208 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
16 |
143 |
5.583e-08 |
1.243e-06 |
209 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
17 |
162 |
5.584e-08 |
1.243e-06 |
210 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
49 |
1021 |
5.624e-08 |
1.246e-06 |
211 |
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
16 |
145 |
6.795e-08 |
1.499e-06 |
212 |
IMMUNE SYSTEM DEVELOPMENT |
34 |
582 |
8.099e-08 |
1.778e-06 |
213 |
REGULATION OF PROTEIN ACETYLATION |
11 |
64 |
8.211e-08 |
1.794e-06 |
214 |
CELL CYCLE G1 S PHASE TRANSITION |
14 |
111 |
8.381e-08 |
1.814e-06 |
215 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
14 |
111 |
8.381e-08 |
1.814e-06 |
216 |
MACROMOLECULAR COMPLEX ASSEMBLY |
60 |
1398 |
8.774e-08 |
1.873e-06 |
217 |
REGULATION OF REPRODUCTIVE PROCESS |
15 |
129 |
8.697e-08 |
1.873e-06 |
218 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
17 |
167 |
8.742e-08 |
1.873e-06 |
219 |
REGULATION OF CYTOSKELETON ORGANIZATION |
31 |
502 |
9.085e-08 |
1.93e-06 |
220 |
SEXUAL REPRODUCTION |
39 |
730 |
9.371e-08 |
1.982e-06 |
221 |
REGULATION OF CELL PROJECTION ORGANIZATION |
33 |
558 |
9.523e-08 |
2.005e-06 |
222 |
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
10 |
52 |
1.055e-07 |
2.212e-06 |
223 |
MORPHOGENESIS OF AN EPITHELIUM |
27 |
400 |
1.073e-07 |
2.239e-06 |
224 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
56 |
1275 |
1.173e-07 |
2.438e-06 |
225 |
POSITIVE REGULATION OF CELL DIVISION |
15 |
132 |
1.183e-07 |
2.446e-06 |
226 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
18 |
191 |
1.193e-07 |
2.455e-06 |
227 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
40 |
767 |
1.205e-07 |
2.471e-06 |
228 |
RESPONSE TO OXIDATIVE STRESS |
25 |
352 |
1.222e-07 |
2.494e-06 |
229 |
CELLULAR RESPONSE TO ALCOHOL |
14 |
115 |
1.315e-07 |
2.672e-06 |
230 |
MACROMOLECULE DEACYLATION |
11 |
67 |
1.341e-07 |
2.713e-06 |
231 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
20 |
236 |
1.378e-07 |
2.777e-06 |
232 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
27 |
406 |
1.449e-07 |
2.894e-06 |
233 |
EMBRYONIC ORGAN DEVELOPMENT |
27 |
406 |
1.449e-07 |
2.894e-06 |
234 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
19 |
216 |
1.586e-07 |
3.153e-06 |
235 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
12 |
84 |
1.77e-07 |
3.504e-06 |
236 |
RESPONSE TO RADIATION |
27 |
413 |
2.041e-07 |
4.023e-06 |
237 |
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
9 |
43 |
2.141e-07 |
4.204e-06 |
238 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
34 |
609 |
2.356e-07 |
4.607e-06 |
239 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
40 |
788 |
2.443e-07 |
4.736e-06 |
240 |
CIRCULATORY SYSTEM DEVELOPMENT |
40 |
788 |
2.443e-07 |
4.736e-06 |
241 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
32 |
554 |
2.545e-07 |
4.914e-06 |
242 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
29 |
472 |
2.656e-07 |
5.107e-06 |
243 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
26 |
393 |
2.738e-07 |
5.242e-06 |
244 |
REGULATION OF DNA REPLICATION |
16 |
161 |
2.919e-07 |
5.567e-06 |
245 |
RESPONSE TO ACID CHEMICAL |
23 |
319 |
3.013e-07 |
5.722e-06 |
246 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
28 |
448 |
3.037e-07 |
5.744e-06 |
247 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
14 |
123 |
3.063e-07 |
5.77e-06 |
248 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
30 |
505 |
3.377e-07 |
6.336e-06 |
249 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
41 |
829 |
3.401e-07 |
6.356e-06 |
250 |
REGULATION OF BODY FLUID LEVELS |
30 |
506 |
3.522e-07 |
6.555e-06 |
251 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
17 |
184 |
3.557e-07 |
6.594e-06 |
252 |
OSSIFICATION |
20 |
251 |
3.731e-07 |
6.889e-06 |
253 |
UROGENITAL SYSTEM DEVELOPMENT |
22 |
299 |
3.867e-07 |
7.112e-06 |
254 |
GAMETE GENERATION |
33 |
595 |
4.139e-07 |
7.582e-06 |
255 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
26 |
404 |
4.651e-07 |
8.486e-06 |
256 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION |
14 |
128 |
5.02e-07 |
9.124e-06 |
257 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
21 |
280 |
5.205e-07 |
9.423e-06 |
258 |
DIGESTIVE SYSTEM DEVELOPMENT |
15 |
148 |
5.323e-07 |
9.601e-06 |
259 |
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS |
11 |
77 |
5.78e-07 |
1.038e-05 |
260 |
RESPONSE TO AMINE |
9 |
48 |
5.805e-07 |
1.039e-05 |
261 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
8 |
36 |
6.282e-07 |
1.12e-05 |
262 |
SENSORY ORGAN DEVELOPMENT |
29 |
493 |
6.513e-07 |
1.157e-05 |
263 |
MUSCLE CELL DIFFERENTIATION |
19 |
237 |
6.658e-07 |
1.178e-05 |
264 |
EPITHELIAL CELL DIFFERENTIATION |
29 |
495 |
7.073e-07 |
1.247e-05 |
265 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
15 |
152 |
7.508e-07 |
1.312e-05 |
266 |
MRNA METABOLIC PROCESS |
33 |
611 |
7.485e-07 |
1.312e-05 |
267 |
BONE MORPHOGENESIS |
11 |
79 |
7.53e-07 |
1.312e-05 |
268 |
POSITIVE REGULATION OF PROTEOLYSIS |
24 |
363 |
8.009e-07 |
1.39e-05 |
269 |
PROTEIN SUMOYLATION |
13 |
115 |
8.779e-07 |
1.518e-05 |
270 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
17 |
197 |
9.328e-07 |
1.608e-05 |
271 |
DNA GEOMETRIC CHANGE |
11 |
81 |
9.73e-07 |
1.671e-05 |
272 |
REGULATION OF PROTEIN STABILITY |
18 |
221 |
1.042e-06 |
1.776e-05 |
273 |
REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE |
7 |
27 |
1.041e-06 |
1.776e-05 |
274 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
17 |
200 |
1.152e-06 |
1.955e-05 |
275 |
CYTOSKELETON ORGANIZATION |
40 |
838 |
1.167e-06 |
1.974e-05 |
276 |
SKELETAL SYSTEM MORPHOGENESIS |
17 |
201 |
1.234e-06 |
2.081e-05 |
277 |
REGULATION OF CYTOPLASMIC TRANSPORT |
28 |
481 |
1.251e-06 |
2.102e-05 |
278 |
CELL ACTIVATION |
31 |
568 |
1.316e-06 |
2.202e-05 |
279 |
NEURON DIFFERENTIATION |
41 |
874 |
1.322e-06 |
2.205e-05 |
280 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
9 |
53 |
1.398e-06 |
2.319e-05 |
281 |
DNA CONFORMATION CHANGE |
20 |
273 |
1.401e-06 |
2.319e-05 |
282 |
REGULATION OF MAPK CASCADE |
34 |
660 |
1.467e-06 |
2.421e-05 |
283 |
RESPONSE TO PEPTIDE |
25 |
404 |
1.581e-06 |
2.6e-05 |
284 |
REGULATION OF GROWTH |
33 |
633 |
1.626e-06 |
2.664e-05 |
285 |
MITOTIC SPINDLE ORGANIZATION |
10 |
69 |
1.652e-06 |
2.697e-05 |
286 |
PLATELET ACTIVATION |
14 |
142 |
1.775e-06 |
2.887e-05 |
287 |
TISSUE REMODELING |
11 |
87 |
2.008e-06 |
3.256e-05 |
288 |
ODONTOGENESIS |
12 |
105 |
2.058e-06 |
3.324e-05 |
289 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
10 |
71 |
2.161e-06 |
3.479e-05 |
290 |
REGULATION OF STEM CELL PROLIFERATION |
11 |
88 |
2.253e-06 |
3.614e-05 |
291 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
56 |
2.261e-06 |
3.616e-05 |
292 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
20 |
282 |
2.309e-06 |
3.654e-05 |
293 |
REGULATION OF NEURON DIFFERENTIATION |
30 |
554 |
2.293e-06 |
3.654e-05 |
294 |
MACROMOLECULE CATABOLIC PROCESS |
42 |
926 |
2.303e-06 |
3.654e-05 |
295 |
RESPONSE TO UV |
13 |
126 |
2.492e-06 |
3.93e-05 |
296 |
HEART MORPHOGENESIS |
17 |
212 |
2.568e-06 |
4.037e-05 |
297 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
16 |
190 |
2.683e-06 |
4.203e-05 |
298 |
PROTEIN COMPLEX BIOGENESIS |
48 |
1132 |
2.743e-06 |
4.269e-05 |
299 |
PROTEIN COMPLEX ASSEMBLY |
48 |
1132 |
2.743e-06 |
4.269e-05 |
300 |
REGULATION OF SUPEROXIDE ANION GENERATION |
5 |
12 |
2.765e-06 |
4.274e-05 |
301 |
REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS |
5 |
12 |
2.765e-06 |
4.274e-05 |
302 |
HEMOSTASIS |
21 |
311 |
2.818e-06 |
4.342e-05 |
303 |
REGULATION OF PROTEOLYSIS |
35 |
711 |
2.847e-06 |
4.371e-05 |
304 |
APPENDAGE DEVELOPMENT |
15 |
169 |
2.87e-06 |
4.379e-05 |
305 |
LIMB DEVELOPMENT |
15 |
169 |
2.87e-06 |
4.379e-05 |
306 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
9 |
58 |
3.063e-06 |
4.644e-05 |
307 |
RESPONSE TO HYDROGEN PEROXIDE |
12 |
109 |
3.064e-06 |
4.644e-05 |
308 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
19 |
263 |
3.153e-06 |
4.764e-05 |
309 |
REGULATION OF CYTOKINE PRODUCTION |
30 |
563 |
3.169e-06 |
4.769e-05 |
310 |
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
8 |
44 |
3.177e-06 |
4.769e-05 |
311 |
SENSORY ORGAN MORPHOGENESIS |
18 |
239 |
3.194e-06 |
4.779e-05 |
312 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
7 |
32 |
3.606e-06 |
5.378e-05 |
313 |
SEX DIFFERENTIATION |
19 |
266 |
3.722e-06 |
5.533e-05 |
314 |
LEUKOCYTE DIFFERENTIATION |
20 |
292 |
3.92e-06 |
5.809e-05 |
315 |
REGULATION OF MICROTUBULE BASED PROCESS |
18 |
243 |
4.034e-06 |
5.959e-05 |
316 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
28 |
513 |
4.321e-06 |
6.362e-05 |
317 |
OVULATION CYCLE |
12 |
113 |
4.482e-06 |
6.577e-05 |
318 |
G2 DNA DAMAGE CHECKPOINT |
7 |
33 |
4.495e-06 |
6.577e-05 |
319 |
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
6 |
22 |
4.579e-06 |
6.659e-05 |
320 |
HISTONE H3 DEACETYLATION |
6 |
22 |
4.579e-06 |
6.659e-05 |
321 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
9 |
61 |
4.719e-06 |
6.841e-05 |
322 |
NEGATIVE REGULATION OF TRANSPORT |
26 |
458 |
4.746e-06 |
6.858e-05 |
323 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
23 |
375 |
4.801e-06 |
6.917e-05 |
324 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
19 |
271 |
4.879e-06 |
7.007e-05 |
325 |
MUSCLE STRUCTURE DEVELOPMENT |
25 |
432 |
5.185e-06 |
7.423e-05 |
326 |
RESPONSE TO ETHANOL |
13 |
136 |
5.845e-06 |
8.342e-05 |
327 |
FEMALE SEX DIFFERENTIATION |
12 |
116 |
5.896e-06 |
8.389e-05 |
328 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
11 |
97 |
5.915e-06 |
8.391e-05 |
329 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
18 |
250 |
5.994e-06 |
8.477e-05 |
330 |
REGULATION OF SUPEROXIDE METABOLIC PROCESS |
6 |
23 |
6.087e-06 |
8.582e-05 |
331 |
HORMONE MEDIATED SIGNALING PATHWAY |
14 |
158 |
6.26e-06 |
8.781e-05 |
332 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
22 |
354 |
6.265e-06 |
8.781e-05 |
333 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
8 |
48 |
6.288e-06 |
8.786e-05 |
334 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
25 |
437 |
6.332e-06 |
8.802e-05 |
335 |
CELLULAR RESPONSE TO RADIATION |
13 |
137 |
6.337e-06 |
8.802e-05 |
336 |
MAMMARY GLAND DEVELOPMENT |
12 |
117 |
6.447e-06 |
8.928e-05 |
337 |
RESPONSE TO VITAMIN |
11 |
98 |
6.539e-06 |
9.029e-05 |
338 |
CELLULAR COMPONENT MORPHOGENESIS |
40 |
900 |
6.592e-06 |
9.075e-05 |
339 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
20 |
303 |
6.82e-06 |
9.361e-05 |
340 |
PROTEIN LOCALIZATION TO ORGANELLE |
29 |
556 |
6.99e-06 |
9.566e-05 |
341 |
WOUND HEALING |
26 |
470 |
7.523e-06 |
0.0001026 |
342 |
RESPONSE TO LIGHT STIMULUS |
19 |
280 |
7.805e-06 |
0.0001062 |
343 |
LOCOMOTION |
46 |
1114 |
8.947e-06 |
0.0001214 |
344 |
RESPONSE TO FATTY ACID |
10 |
83 |
9.105e-06 |
0.0001232 |
345 |
REGULATION OF WNT SIGNALING PATHWAY |
20 |
310 |
9.558e-06 |
0.0001289 |
346 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
16 |
211 |
1.029e-05 |
0.0001383 |
347 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
9 |
67 |
1.042e-05 |
0.0001397 |
348 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
10 |
85 |
1.129e-05 |
0.0001505 |
349 |
POSITIVE REGULATION OF CHROMATIN MODIFICATION |
10 |
85 |
1.129e-05 |
0.0001505 |
350 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
11 |
104 |
1.164e-05 |
0.0001547 |
351 |
POSITIVE REGULATION OF KINASE ACTIVITY |
26 |
482 |
1.171e-05 |
0.0001552 |
352 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
12 |
124 |
1.174e-05 |
0.0001552 |
353 |
RESPONSE TO IONIZING RADIATION |
13 |
145 |
1.178e-05 |
0.0001553 |
354 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
18 |
263 |
1.202e-05 |
0.0001576 |
355 |
STEM CELL DIFFERENTIATION |
15 |
190 |
1.2e-05 |
0.0001576 |
356 |
REGULATION OF DOUBLE STRAND BREAK REPAIR |
7 |
38 |
1.213e-05 |
0.0001586 |
357 |
POSITIVE REGULATION OF DNA REPLICATION |
10 |
86 |
1.254e-05 |
0.0001634 |
358 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
14 |
168 |
1.268e-05 |
0.0001649 |
359 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
12 |
125 |
1.275e-05 |
0.0001652 |
360 |
DNA RECOMBINATION |
16 |
215 |
1.302e-05 |
0.0001683 |
361 |
MALE GAMETE GENERATION |
26 |
486 |
1.352e-05 |
0.0001743 |
362 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
15 |
192 |
1.36e-05 |
0.0001748 |
363 |
REGULATION OF MAP KINASE ACTIVITY |
20 |
319 |
1.452e-05 |
0.0001861 |
364 |
RNA SPLICING VIA TRANSESTERIFICATION REACTIONS |
18 |
267 |
1.475e-05 |
0.0001885 |
365 |
REGULATION OF MEMBRANE PERMEABILITY |
9 |
70 |
1.499e-05 |
0.0001911 |
366 |
MRNA PROCESSING |
24 |
432 |
1.574e-05 |
0.0002001 |
367 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
35 |
771 |
1.637e-05 |
0.0002076 |
368 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
55 |
1.785e-05 |
0.0002251 |
369 |
REGULATION OF KIDNEY DEVELOPMENT |
8 |
55 |
1.785e-05 |
0.0002251 |
370 |
WNT SIGNALING PATHWAY |
21 |
351 |
1.801e-05 |
0.0002264 |
371 |
POSITIVE REGULATION OF LIGASE ACTIVITY |
11 |
110 |
1.988e-05 |
0.0002493 |
372 |
GROWTH |
23 |
410 |
2.028e-05 |
0.0002536 |
373 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
7 |
41 |
2.047e-05 |
0.0002547 |
374 |
PROSTATE GLAND DEVELOPMENT |
7 |
41 |
2.047e-05 |
0.0002547 |
375 |
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
6 |
28 |
2.079e-05 |
0.0002579 |
376 |
CELL CYCLE ARREST |
13 |
154 |
2.249e-05 |
0.0002783 |
377 |
APOPTOTIC MITOCHONDRIAL CHANGES |
8 |
57 |
2.336e-05 |
0.0002883 |
378 |
NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC |
11 |
112 |
2.357e-05 |
0.0002894 |
379 |
EAR MORPHOGENESIS |
11 |
112 |
2.357e-05 |
0.0002894 |
380 |
PITUITARY GLAND DEVELOPMENT |
7 |
42 |
2.413e-05 |
0.0002954 |
381 |
NCRNA METABOLIC PROCESS |
27 |
533 |
2.429e-05 |
0.0002959 |
382 |
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
14 |
178 |
2.435e-05 |
0.0002959 |
383 |
REGULATION OF OSSIFICATION |
14 |
178 |
2.435e-05 |
0.0002959 |
384 |
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
6 |
29 |
2.575e-05 |
0.0003096 |
385 |
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
6 |
29 |
2.575e-05 |
0.0003096 |
386 |
MESENCHYMAL CELL DIFFERENTIATION |
12 |
134 |
2.575e-05 |
0.0003096 |
387 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
6 |
29 |
2.575e-05 |
0.0003096 |
388 |
REGULATION OF DNA REPAIR |
9 |
75 |
2.64e-05 |
0.0003158 |
389 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
9 |
75 |
2.64e-05 |
0.0003158 |
390 |
RESPONSE TO METAL ION |
20 |
333 |
2.692e-05 |
0.0003204 |
391 |
DEVELOPMENTAL GROWTH |
20 |
333 |
2.692e-05 |
0.0003204 |
392 |
PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION |
16 |
229 |
2.837e-05 |
0.0003367 |
393 |
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS |
8 |
59 |
3.022e-05 |
0.0003569 |
394 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
8 |
59 |
3.022e-05 |
0.0003569 |
395 |
RESPONSE TO AMPHETAMINE |
6 |
30 |
3.162e-05 |
0.0003715 |
396 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
6 |
30 |
3.162e-05 |
0.0003715 |
397 |
DIENCEPHALON DEVELOPMENT |
9 |
77 |
3.268e-05 |
0.000383 |
398 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
10 |
96 |
3.316e-05 |
0.0003877 |
399 |
IN UTERO EMBRYONIC DEVELOPMENT |
19 |
311 |
3.382e-05 |
0.0003944 |
400 |
RNA SPLICING |
21 |
367 |
3.473e-05 |
0.000404 |
401 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
18 |
285 |
3.516e-05 |
0.0004079 |
402 |
NEURON PROJECTION DEVELOPMENT |
27 |
545 |
3.572e-05 |
0.0004135 |
403 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
5 |
19 |
3.595e-05 |
0.0004151 |
404 |
CELL MOTILITY |
36 |
835 |
3.677e-05 |
0.0004225 |
405 |
LOCALIZATION OF CELL |
36 |
835 |
3.677e-05 |
0.0004225 |
406 |
LYMPHOCYTE DIFFERENTIATION |
15 |
209 |
3.686e-05 |
0.0004225 |
407 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
8 |
61 |
3.87e-05 |
0.0004424 |
408 |
PROTEIN LOCALIZATION |
63 |
1805 |
3.89e-05 |
0.0004436 |
409 |
PROTEIN CATABOLIC PROCESS |
28 |
579 |
3.927e-05 |
0.0004468 |
410 |
PEPTIDYL TYROSINE MODIFICATION |
14 |
186 |
3.965e-05 |
0.00045 |
411 |
REGULATION OF HYDROLASE ACTIVITY |
50 |
1327 |
4.076e-05 |
0.0004614 |
412 |
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
37 |
873 |
4.105e-05 |
0.0004636 |
413 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
11 |
119 |
4.156e-05 |
0.0004682 |
414 |
CARDIAC VENTRICLE MORPHOGENESIS |
8 |
62 |
4.363e-05 |
0.0004891 |
415 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
8 |
62 |
4.363e-05 |
0.0004891 |
416 |
RESPONSE TO COCAINE |
7 |
46 |
4.454e-05 |
0.0004958 |
417 |
NEGATIVE REGULATION OF DNA BINDING |
7 |
46 |
4.454e-05 |
0.0004958 |
418 |
NEURON PROJECTION MORPHOGENESIS |
22 |
402 |
4.441e-05 |
0.0004958 |
419 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
17 |
264 |
4.533e-05 |
0.0005022 |
420 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE |
17 |
264 |
4.533e-05 |
0.0005022 |
421 |
MICROTUBULE BASED PROCESS |
26 |
522 |
4.554e-05 |
0.0005033 |
422 |
MULTI MULTICELLULAR ORGANISM PROCESS |
15 |
213 |
4.586e-05 |
0.0005057 |
423 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR |
6 |
32 |
4.658e-05 |
0.0005124 |
424 |
MYELOID CELL DIFFERENTIATION |
14 |
189 |
4.726e-05 |
0.0005186 |
425 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
20 |
348 |
5.004e-05 |
0.0005478 |
426 |
SECRETION |
28 |
588 |
5.14e-05 |
0.0005614 |
427 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
12 |
144 |
5.25e-05 |
0.0005721 |
428 |
HEART DEVELOPMENT |
24 |
466 |
5.299e-05 |
0.0005761 |
429 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
15 |
216 |
5.383e-05 |
0.0005838 |
430 |
REGULATION OF CYTOKINESIS |
8 |
64 |
5.507e-05 |
0.0005945 |
431 |
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
8 |
64 |
5.507e-05 |
0.0005945 |
432 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
22 |
408 |
5.532e-05 |
0.0005958 |
433 |
VIRAL LATENCY |
4 |
11 |
5.576e-05 |
0.0005992 |
434 |
REGULATION OF CELL AGING |
6 |
33 |
5.593e-05 |
0.0005997 |
435 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
10 |
103 |
6.091e-05 |
0.0006486 |
436 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
10 |
103 |
6.091e-05 |
0.0006486 |
437 |
BONE RESORPTION |
5 |
21 |
6.078e-05 |
0.0006486 |
438 |
REGULATION OF METAL ION TRANSPORT |
19 |
325 |
6.125e-05 |
0.0006506 |
439 |
CARDIAC CHAMBER MORPHOGENESIS |
10 |
104 |
6.616e-05 |
0.0006999 |
440 |
REGULATION OF RESPONSE TO WOUNDING |
22 |
413 |
6.618e-05 |
0.0006999 |
441 |
EAR DEVELOPMENT |
14 |
195 |
6.638e-05 |
0.0007003 |
442 |
TISSUE HOMEOSTASIS |
13 |
171 |
6.717e-05 |
0.0007071 |
443 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
12 |
148 |
6.856e-05 |
0.0007201 |
444 |
CELLULAR RESPONSE TO UV |
8 |
66 |
6.89e-05 |
0.000722 |
445 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
11 |
126 |
7.028e-05 |
0.0007348 |
446 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
17 |
274 |
7.191e-05 |
0.0007502 |
447 |
POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION |
5 |
22 |
7.731e-05 |
0.000798 |
448 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
5 |
22 |
7.731e-05 |
0.000798 |
449 |
REGULATION OF SECRETION |
31 |
699 |
7.728e-05 |
0.000798 |
450 |
RESPONSE TO PROGESTERONE |
7 |
50 |
7.735e-05 |
0.000798 |
451 |
RESPONSE TO GAMMA RADIATION |
7 |
50 |
7.735e-05 |
0.000798 |
452 |
REGULATION OF PROTEIN OLIGOMERIZATION |
6 |
35 |
7.912e-05 |
0.0008091 |
453 |
BONE REMODELING |
6 |
35 |
7.912e-05 |
0.0008091 |
454 |
RESPONSE TO MINERALOCORTICOID |
6 |
35 |
7.912e-05 |
0.0008091 |
455 |
PATTERN SPECIFICATION PROCESS |
22 |
418 |
7.891e-05 |
0.0008091 |
456 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
11 |
128 |
8.109e-05 |
0.0008275 |
457 |
REGULATION OF IMMUNE SYSTEM PROCESS |
51 |
1403 |
8.48e-05 |
0.0008634 |
458 |
CELLULAR RESPONSE TO ACID CHEMICAL |
13 |
175 |
8.507e-05 |
0.0008643 |
459 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
8 |
68 |
8.55e-05 |
0.0008667 |
460 |
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM |
16 |
252 |
8.911e-05 |
0.0009013 |
461 |
EMBRYONIC ORGAN MORPHOGENESIS |
17 |
279 |
8.975e-05 |
0.0009059 |
462 |
REGULATION OF LIGASE ACTIVITY |
11 |
130 |
9.33e-05 |
0.0009356 |
463 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
6 |
36 |
9.328e-05 |
0.0009356 |
464 |
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY |
6 |
36 |
9.328e-05 |
0.0009356 |
465 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
12 |
153 |
9.445e-05 |
0.0009451 |
466 |
CHROMATIN ASSEMBLY OR DISASSEMBLY |
13 |
177 |
9.548e-05 |
0.0009533 |
467 |
CELLULAR COMPONENT DISASSEMBLY |
25 |
515 |
9.573e-05 |
0.0009538 |
468 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
20 |
365 |
9.637e-05 |
0.0009582 |
469 |
REGULATION OF NUCLEASE ACTIVITY |
5 |
23 |
9.709e-05 |
0.0009592 |
470 |
LEUKOCYTE APOPTOTIC PROCESS |
5 |
23 |
9.709e-05 |
0.0009592 |
471 |
PROTEIN INSERTION INTO MEMBRANE |
5 |
23 |
9.709e-05 |
0.0009592 |
472 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
21 |
395 |
9.927e-05 |
0.0009786 |
473 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
7 |
52 |
9.994e-05 |
0.0009831 |
474 |
IMMUNE SYSTEM PROCESS |
66 |
1984 |
0.0001056 |
0.001037 |
475 |
REGIONALIZATION |
18 |
311 |
0.000108 |
0.001058 |
476 |
REGULATION OF RECEPTOR INTERNALIZATION |
6 |
37 |
0.0001094 |
0.001069 |
477 |
MESONEPHROS DEVELOPMENT |
9 |
90 |
0.0001126 |
0.001099 |
478 |
MACROMOLECULE METHYLATION |
14 |
205 |
0.0001134 |
0.001104 |
479 |
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
10 |
111 |
0.0001147 |
0.00111 |
480 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
10 |
111 |
0.0001147 |
0.00111 |
481 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
10 |
111 |
0.0001147 |
0.00111 |
482 |
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
4 |
13 |
0.0001169 |
0.001119 |
483 |
MITOTIC G2 DNA DAMAGE CHECKPOINT |
4 |
13 |
0.0001169 |
0.001119 |
484 |
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE |
4 |
13 |
0.0001169 |
0.001119 |
485 |
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT |
4 |
13 |
0.0001169 |
0.001119 |
486 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
17 |
285 |
0.0001162 |
0.001119 |
487 |
PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
11 |
134 |
0.0001225 |
0.00117 |
488 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
10 |
112 |
0.0001237 |
0.001179 |
489 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
20 |
372 |
0.0001245 |
0.001185 |
490 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
14 |
207 |
0.0001256 |
0.001193 |
491 |
RESPONSE TO TESTOSTERONE |
6 |
38 |
0.0001276 |
0.001207 |
492 |
MESENCHYME MORPHOGENESIS |
6 |
38 |
0.0001276 |
0.001207 |
493 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
9 |
92 |
0.0001336 |
0.001261 |
494 |
CATABOLIC PROCESS |
60 |
1773 |
0.0001432 |
0.001348 |
495 |
NEGATIVE REGULATION OF DNA REPLICATION |
7 |
55 |
0.0001436 |
0.00135 |
496 |
NEGATIVE REGULATION OF ENDOCYTOSIS |
6 |
39 |
0.0001482 |
0.001385 |
497 |
BASE EXCISION REPAIR |
6 |
39 |
0.0001482 |
0.001385 |
498 |
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
5 |
25 |
0.0001481 |
0.001385 |
499 |
RESPONSE TO ALKALOID |
11 |
137 |
0.0001492 |
0.001391 |
500 |
VASCULATURE DEVELOPMENT |
23 |
469 |
0.0001562 |
0.001454 |
501 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
7 |
56 |
0.0001612 |
0.001477 |
502 |
REGULATION OF HISTONE METHYLATION |
7 |
56 |
0.0001612 |
0.001477 |
503 |
SPECIFICATION OF ORGAN IDENTITY |
4 |
14 |
0.0001609 |
0.001477 |
504 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
14 |
0.0001609 |
0.001477 |
505 |
MULTI ORGANISM METABOLIC PROCESS |
11 |
138 |
0.0001591 |
0.001477 |
506 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
7 |
56 |
0.0001612 |
0.001477 |
507 |
OUTFLOW TRACT MORPHOGENESIS |
7 |
56 |
0.0001612 |
0.001477 |
508 |
PEPTIDYL ARGININE METHYLATION |
4 |
14 |
0.0001609 |
0.001477 |
509 |
MEMBRANE ORGANIZATION |
36 |
899 |
0.000162 |
0.001478 |
510 |
ANGIOGENESIS |
17 |
293 |
0.000162 |
0.001478 |
511 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
12 |
162 |
0.0001625 |
0.00148 |
512 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
11 |
139 |
0.0001696 |
0.001541 |
513 |
PROTEIN METHYLATION |
10 |
117 |
0.0001777 |
0.001609 |
514 |
PROTEIN ALKYLATION |
10 |
117 |
0.0001777 |
0.001609 |
515 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
5 |
26 |
0.0001802 |
0.001628 |
516 |
MYELOID LEUKOCYTE DIFFERENTIATION |
9 |
96 |
0.0001852 |
0.00167 |
517 |
REGULATION OF SYSTEM PROCESS |
24 |
507 |
0.0001919 |
0.001727 |
518 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
11 |
141 |
0.0001924 |
0.001728 |
519 |
EYE DEVELOPMENT |
18 |
326 |
0.0001941 |
0.00174 |
520 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
6 |
41 |
0.0001971 |
0.001761 |
521 |
ANDROGEN RECEPTOR SIGNALING PATHWAY |
6 |
41 |
0.0001971 |
0.001761 |
522 |
GLAND MORPHOGENESIS |
9 |
97 |
0.0002004 |
0.001787 |
523 |
NCRNA PROCESSING |
20 |
386 |
0.0002034 |
0.00181 |
524 |
REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY |
4 |
15 |
0.0002158 |
0.001898 |
525 |
OTIC VESICLE DEVELOPMENT |
4 |
15 |
0.0002158 |
0.001898 |
526 |
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY |
4 |
15 |
0.0002158 |
0.001898 |
527 |
HISTONE H2A ACETYLATION |
4 |
15 |
0.0002158 |
0.001898 |
528 |
POSITIVE REGULATION OF NUCLEASE ACTIVITY |
4 |
15 |
0.0002158 |
0.001898 |
529 |
ACTIVATION OF ANAPHASE PROMOTING COMPLEX ACTIVITY |
4 |
15 |
0.0002158 |
0.001898 |
530 |
POSITIVE REGULATION OF HEART GROWTH |
5 |
27 |
0.0002174 |
0.001909 |
531 |
REGULATION OF DENDRITE DEVELOPMENT |
10 |
120 |
0.0002188 |
0.001917 |
532 |
ACTIN FILAMENT BASED PROCESS |
22 |
450 |
0.0002257 |
0.001963 |
533 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
6 |
42 |
0.000226 |
0.001963 |
534 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
8 |
78 |
0.0002261 |
0.001963 |
535 |
DNA METHYLATION OR DEMETHYLATION |
7 |
59 |
0.0002247 |
0.001963 |
536 |
REGULATION OF HEART GROWTH |
6 |
42 |
0.000226 |
0.001963 |
537 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
11 |
144 |
0.0002313 |
0.002004 |
538 |
CELLULAR RESPONSE TO PEPTIDE |
16 |
274 |
0.0002332 |
0.002016 |
539 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
13 |
194 |
0.000238 |
0.00205 |
540 |
DNA PACKAGING |
13 |
194 |
0.000238 |
0.00205 |
541 |
NEGATIVE REGULATION OF MAPK CASCADE |
11 |
145 |
0.0002457 |
0.002113 |
542 |
DNA MODIFICATION |
8 |
79 |
0.000247 |
0.002121 |
543 |
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION |
14 |
221 |
0.0002483 |
0.002128 |
544 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
10 |
122 |
0.0002504 |
0.002133 |
545 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
7 |
60 |
0.0002499 |
0.002133 |
546 |
REGULATION OF MUSCLE SYSTEM PROCESS |
13 |
195 |
0.0002502 |
0.002133 |
547 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
100 |
0.0002525 |
0.002144 |
548 |
LIMBIC SYSTEM DEVELOPMENT |
9 |
100 |
0.0002525 |
0.002144 |
549 |
PROTEIN PEPTIDYL PROLYL ISOMERIZATION |
6 |
43 |
0.000258 |
0.002187 |
550 |
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
28 |
0.0002602 |
0.002197 |
551 |
MAMMARY GLAND DUCT MORPHOGENESIS |
5 |
28 |
0.0002602 |
0.002197 |
552 |
BLOOD VESSEL MORPHOGENESIS |
19 |
364 |
0.0002658 |
0.002241 |
553 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
17 |
306 |
0.0002702 |
0.002273 |
554 |
CARTILAGE DEVELOPMENT |
11 |
147 |
0.0002767 |
0.002324 |
555 |
DNA LIGATION |
4 |
16 |
0.000283 |
0.002368 |
556 |
MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN |
4 |
16 |
0.000283 |
0.002368 |
557 |
RIBOSOME BIOGENESIS |
17 |
308 |
0.0002914 |
0.002435 |
558 |
MALE SEX DIFFERENTIATION |
11 |
148 |
0.0002934 |
0.002447 |
559 |
NEURON DEVELOPMENT |
29 |
687 |
0.0003005 |
0.002501 |
560 |
KIDNEY EPITHELIUM DEVELOPMENT |
10 |
125 |
0.0003048 |
0.002533 |
561 |
REGULATION OF TISSUE REMODELING |
7 |
62 |
0.000307 |
0.002546 |
562 |
REGULATION OF HEART MORPHOGENESIS |
5 |
29 |
0.000309 |
0.002554 |
563 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
5 |
29 |
0.000309 |
0.002554 |
564 |
REGULATION OF CIRCADIAN RHYTHM |
9 |
103 |
0.0003153 |
0.002597 |
565 |
REGULATION OF CALCIUM ION IMPORT |
9 |
103 |
0.0003153 |
0.002597 |
566 |
DNA METHYLATION |
6 |
45 |
0.0003328 |
0.002726 |
567 |
ENDOCHONDRAL BONE MORPHOGENESIS |
6 |
45 |
0.0003328 |
0.002726 |
568 |
DNA ALKYLATION |
6 |
45 |
0.0003328 |
0.002726 |
569 |
REGULATION OF ION TRANSPORT |
26 |
592 |
0.0003379 |
0.002763 |
570 |
TAXIS |
22 |
464 |
0.0003443 |
0.002811 |
571 |
EMBRYONIC PLACENTA DEVELOPMENT |
8 |
83 |
0.0003474 |
0.002826 |
572 |
LYMPHOCYTE ACTIVATION |
18 |
342 |
0.0003469 |
0.002826 |
573 |
HOMEOSTATIC PROCESS |
47 |
1337 |
0.0003487 |
0.002832 |
574 |
NUCLEOSOME DISASSEMBLY |
4 |
17 |
0.000364 |
0.002939 |
575 |
PROTEIN DNA COMPLEX DISASSEMBLY |
4 |
17 |
0.000364 |
0.002939 |
576 |
CHROMATIN DISASSEMBLY |
4 |
17 |
0.000364 |
0.002939 |
577 |
RESPONSE TO X RAY |
5 |
30 |
0.0003645 |
0.002939 |
578 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
11 |
152 |
0.000369 |
0.002971 |
579 |
PEPTIDYL THREONINE MODIFICATION |
6 |
46 |
0.000376 |
0.003022 |
580 |
HISTONE METHYLATION |
8 |
84 |
0.000377 |
0.003025 |
581 |
CARDIAC VENTRICLE DEVELOPMENT |
9 |
106 |
0.0003905 |
0.003128 |
582 |
PROTEIN LOCALIZATION TO MEMBRANE |
19 |
376 |
0.0003979 |
0.003181 |
583 |
CELLULAR MACROMOLECULE LOCALIZATION |
44 |
1234 |
0.0004028 |
0.003215 |
584 |
POSITIVE REGULATION OF MAPK CASCADE |
22 |
470 |
0.00041 |
0.003267 |
585 |
CELL PART MORPHOGENESIS |
27 |
633 |
0.0004114 |
0.003272 |
586 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
11 |
154 |
0.0004126 |
0.003276 |
587 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
9 |
107 |
0.0004187 |
0.003319 |
588 |
REGULATION OF DEVELOPMENTAL GROWTH |
16 |
289 |
0.0004216 |
0.003336 |
589 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE |
6 |
47 |
0.0004235 |
0.00334 |
590 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
6 |
47 |
0.0004235 |
0.00334 |
591 |
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS |
21 |
440 |
0.0004283 |
0.003372 |
592 |
VIRAL LIFE CYCLE |
16 |
290 |
0.0004378 |
0.003441 |
593 |
PROTEIN STABILIZATION |
10 |
131 |
0.0004437 |
0.003481 |
594 |
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY |
4 |
18 |
0.0004603 |
0.003588 |
595 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
11 |
156 |
0.0004603 |
0.003588 |
596 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
11 |
156 |
0.0004603 |
0.003588 |
597 |
LYMPHOCYTE APOPTOTIC PROCESS |
4 |
18 |
0.0004603 |
0.003588 |
598 |
DIGESTIVE TRACT MORPHOGENESIS |
6 |
48 |
0.0004756 |
0.0037 |
599 |
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
8 |
87 |
0.0004786 |
0.003718 |
600 |
GERM CELL DEVELOPMENT |
13 |
209 |
0.0004874 |
0.00378 |
601 |
ENDOCARDIAL CUSHION DEVELOPMENT |
5 |
32 |
0.0004977 |
0.00384 |
602 |
REGULATION OF TELOMERE MAINTENANCE |
7 |
67 |
0.0004964 |
0.00384 |
603 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
5 |
32 |
0.0004977 |
0.00384 |
604 |
NEGATIVE REGULATION OF CELL ACTIVATION |
11 |
158 |
0.0005127 |
0.00395 |
605 |
POSITIVE REGULATION OF GROWTH |
14 |
238 |
0.0005247 |
0.004035 |
606 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
10 |
134 |
0.0005308 |
0.004075 |
607 |
POST EMBRYONIC DEVELOPMENT |
8 |
89 |
0.0005579 |
0.004276 |
608 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.0005734 |
0.004345 |
609 |
CELLULAR RESPONSE TO GAMMA RADIATION |
4 |
19 |
0.0005734 |
0.004345 |
610 |
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION |
4 |
19 |
0.0005734 |
0.004345 |
611 |
PEPTIDYL ARGININE MODIFICATION |
4 |
19 |
0.0005734 |
0.004345 |
612 |
MITOTIC G2 M TRANSITION CHECKPOINT |
4 |
19 |
0.0005734 |
0.004345 |
613 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
4 |
19 |
0.0005734 |
0.004345 |
614 |
ATRIOVENTRICULAR VALVE DEVELOPMENT |
4 |
19 |
0.0005734 |
0.004345 |
615 |
CELLULAR SENESCENCE |
5 |
33 |
0.0005765 |
0.004353 |
616 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
35 |
926 |
0.0005773 |
0.004353 |
617 |
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
5 |
33 |
0.0005765 |
0.004353 |
618 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
55 |
1676 |
0.0005865 |
0.004416 |
619 |
LYMPHOCYTE HOMEOSTASIS |
6 |
50 |
0.0005946 |
0.004462 |
620 |
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING |
6 |
50 |
0.0005946 |
0.004462 |
621 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
10 |
136 |
0.0005963 |
0.004468 |
622 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
90 |
0.0006013 |
0.004498 |
623 |
NUCLEOTIDE EXCISION REPAIR |
9 |
113 |
0.0006246 |
0.004665 |
624 |
CELL CHEMOTAXIS |
11 |
162 |
0.0006324 |
0.004708 |
625 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
11 |
162 |
0.0006324 |
0.004708 |
626 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
8 |
91 |
0.0006474 |
0.004812 |
627 |
MUSCLE ORGAN MORPHOGENESIS |
7 |
70 |
0.0006485 |
0.004813 |
628 |
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
6 |
51 |
0.0006621 |
0.004898 |
629 |
CELLULAR RESPONSE TO FATTY ACID |
6 |
51 |
0.0006621 |
0.004898 |
630 |
HEART VALVE DEVELOPMENT |
5 |
34 |
0.0006644 |
0.004907 |
631 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
34 |
898 |
0.0006705 |
0.004944 |
632 |
REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
13 |
217 |
0.0006936 |
0.005107 |
633 |
MESENCHYME DEVELOPMENT |
12 |
190 |
0.0006949 |
0.005108 |
634 |
INNER EAR MORPHOGENESIS |
8 |
92 |
0.0006964 |
0.005111 |
635 |
NEGATIVE REGULATION OF CELL CYCLE ARREST |
4 |
20 |
0.000705 |
0.005125 |
636 |
GENETIC IMPRINTING |
4 |
20 |
0.000705 |
0.005125 |
637 |
PROTEIN REFOLDING |
4 |
20 |
0.000705 |
0.005125 |
638 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
0.000705 |
0.005125 |
639 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
4 |
20 |
0.000705 |
0.005125 |
640 |
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY |
4 |
20 |
0.000705 |
0.005125 |
641 |
SKIN EPIDERMIS DEVELOPMENT |
7 |
71 |
0.0007067 |
0.00513 |
642 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
6 |
52 |
0.0007354 |
0.005314 |
643 |
NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
6 |
52 |
0.0007354 |
0.005314 |
644 |
CELLULAR RESPONSE TO IONIZING RADIATION |
6 |
52 |
0.0007354 |
0.005314 |
645 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
8 |
93 |
0.0007482 |
0.005389 |
646 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
10 |
140 |
0.0007476 |
0.005389 |
647 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
8 |
94 |
0.0008032 |
0.005776 |
648 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
6 |
53 |
0.0008149 |
0.005851 |
649 |
PANCREAS DEVELOPMENT |
7 |
73 |
0.0008355 |
0.005962 |
650 |
REGULATION OF ORGAN GROWTH |
7 |
73 |
0.0008355 |
0.005962 |
651 |
CONNECTIVE TISSUE DEVELOPMENT |
12 |
194 |
0.0008344 |
0.005962 |
652 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
7 |
73 |
0.0008355 |
0.005962 |
653 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
8 |
95 |
0.0008613 |
0.006128 |
654 |
CHROMATIN SILENCING |
8 |
95 |
0.0008613 |
0.006128 |
655 |
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS |
6 |
54 |
0.0009008 |
0.006379 |
656 |
CARDIAC MUSCLE TISSUE MORPHOGENESIS |
6 |
54 |
0.0009008 |
0.006379 |
657 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
6 |
54 |
0.0009008 |
0.006379 |
658 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
74 |
0.0009064 |
0.00641 |
659 |
CELLULAR CATABOLIC PROCESS |
45 |
1322 |
0.0009126 |
0.006444 |
660 |
FEMALE GAMETE GENERATION |
8 |
96 |
0.0009228 |
0.006506 |
661 |
CARDIAC CHAMBER DEVELOPMENT |
10 |
144 |
0.0009292 |
0.006538 |
662 |
PROTEIN FOLDING |
13 |
224 |
0.0009301 |
0.006538 |
663 |
NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
11 |
170 |
0.0009421 |
0.006612 |
664 |
MUSCLE SYSTEM PROCESS |
15 |
282 |
0.0009504 |
0.00666 |
665 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
12 |
197 |
0.0009537 |
0.006673 |
666 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
7 |
75 |
0.000982 |
0.006861 |
667 |
HINDLIMB MORPHOGENESIS |
5 |
37 |
0.0009887 |
0.006866 |
668 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
5 |
37 |
0.0009887 |
0.006866 |
669 |
ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY |
5 |
37 |
0.0009887 |
0.006866 |
670 |
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY |
5 |
37 |
0.0009887 |
0.006866 |
671 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
6 |
55 |
0.0009935 |
0.006889 |
672 |
METHYLATION |
15 |
284 |
0.00102 |
0.007065 |
673 |
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS |
4 |
22 |
0.00103 |
0.007067 |
674 |
SEX DETERMINATION |
4 |
22 |
0.00103 |
0.007067 |
675 |
RRNA METABOLIC PROCESS |
14 |
255 |
0.001028 |
0.007067 |
676 |
REGULATION OF HEMOPOIESIS |
16 |
314 |
0.001026 |
0.007067 |
677 |
AORTA MORPHOGENESIS |
4 |
22 |
0.00103 |
0.007067 |
678 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
4 |
22 |
0.00103 |
0.007067 |
679 |
REGULATION OF ENDOCYTOSIS |
12 |
199 |
0.001041 |
0.007133 |
680 |
REGULATION OF PROTEIN TARGETING TO MITOCHONDRION |
8 |
98 |
0.001056 |
0.007206 |
681 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
8 |
98 |
0.001056 |
0.007206 |
682 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
98 |
0.001056 |
0.007206 |
683 |
EXTRACELLULAR MATRIX DISASSEMBLY |
7 |
76 |
0.001063 |
0.007239 |
684 |
REGULATION OF MUSCLE CONTRACTION |
10 |
147 |
0.001088 |
0.0074 |
685 |
ACTIN MYOSIN FILAMENT SLIDING |
5 |
38 |
0.001119 |
0.007569 |
686 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
5 |
38 |
0.001119 |
0.007569 |
687 |
MUSCLE FILAMENT SLIDING |
5 |
38 |
0.001119 |
0.007569 |
688 |
POSITIVE REGULATION OF ORGAN GROWTH |
5 |
38 |
0.001119 |
0.007569 |
689 |
REGULATION OF ION HOMEOSTASIS |
12 |
201 |
0.001135 |
0.007663 |
690 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
6 |
57 |
0.001201 |
0.008085 |
691 |
PEPTIDYL PROLINE MODIFICATION |
6 |
57 |
0.001201 |
0.008085 |
692 |
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM |
8 |
100 |
0.001205 |
0.008089 |
693 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
8 |
100 |
0.001205 |
0.008089 |
694 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
18 |
381 |
0.001212 |
0.008124 |
695 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
15 |
289 |
0.001215 |
0.008132 |
696 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
4 |
23 |
0.001226 |
0.008173 |
697 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS |
4 |
23 |
0.001226 |
0.008173 |
698 |
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS |
4 |
23 |
0.001226 |
0.008173 |
699 |
LEUKOCYTE ACTIVATION |
19 |
414 |
0.001256 |
0.008361 |
700 |
ANATOMICAL STRUCTURE MATURATION |
5 |
39 |
0.001262 |
0.008364 |
701 |
PLATELET AGGREGATION |
5 |
39 |
0.001262 |
0.008364 |
702 |
GLANDULAR EPITHELIAL CELL DIFFERENTIATION |
5 |
39 |
0.001262 |
0.008364 |
703 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
13 |
232 |
0.00128 |
0.00847 |
704 |
ORGANELLE LOCALIZATION |
19 |
415 |
0.001291 |
0.008536 |
705 |
MITOCHONDRIAL TRANSPORT |
11 |
177 |
0.001307 |
0.008628 |
706 |
REGULATION OF DNA RECOMBINATION |
6 |
58 |
0.001316 |
0.008636 |
707 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
13 |
233 |
0.00133 |
0.008636 |
708 |
ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME |
3 |
11 |
0.001329 |
0.008636 |
709 |
POSITIVE REGULATION OF HORMONE METABOLIC PROCESS |
3 |
11 |
0.001329 |
0.008636 |
710 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
14 |
262 |
0.001331 |
0.008636 |
711 |
REGULATION OF INTERLEUKIN 1 PRODUCTION |
6 |
58 |
0.001316 |
0.008636 |
712 |
ORGANELLE INHERITANCE |
3 |
11 |
0.001329 |
0.008636 |
713 |
PROSTATE GLAND GROWTH |
3 |
11 |
0.001329 |
0.008636 |
714 |
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION |
3 |
11 |
0.001329 |
0.008636 |
715 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT |
3 |
11 |
0.001329 |
0.008636 |
716 |
REGULATION OF HISTONE H4 ACETYLATION |
3 |
11 |
0.001329 |
0.008636 |
717 |
PROSTATE GLANDULAR ACINUS DEVELOPMENT |
3 |
11 |
0.001329 |
0.008636 |
718 |
PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS |
7 |
79 |
0.001335 |
0.008655 |
719 |
RESPONSE TO INSULIN |
12 |
205 |
0.001343 |
0.008692 |
720 |
REGULATION OF WOUND HEALING |
9 |
126 |
0.001359 |
0.008781 |
721 |
REGULATION OF LEUKOCYTE PROLIFERATION |
12 |
206 |
0.0014 |
0.009035 |
722 |
MAMMARY GLAND MORPHOGENESIS |
5 |
40 |
0.001418 |
0.009111 |
723 |
ENDOCRINE PANCREAS DEVELOPMENT |
5 |
40 |
0.001418 |
0.009111 |
724 |
CELL PROJECTION ORGANIZATION |
33 |
902 |
0.001417 |
0.009111 |
725 |
REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY |
9 |
127 |
0.001436 |
0.009203 |
726 |
NEGATIVE REGULATION OF ION TRANSPORT |
9 |
127 |
0.001436 |
0.009203 |
727 |
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
6 |
59 |
0.00144 |
0.009214 |
728 |
HYPOTHALAMUS DEVELOPMENT |
4 |
24 |
0.001447 |
0.00925 |
729 |
REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
8 |
103 |
0.001458 |
0.009298 |
730 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
12 |
207 |
0.001459 |
0.009298 |
731 |
POSITIVE REGULATION OF LOCOMOTION |
19 |
420 |
0.001482 |
0.009434 |
732 |
SECRETION BY CELL |
21 |
486 |
0.001506 |
0.009572 |
733 |
DNA REPLICATION |
12 |
208 |
0.00152 |
0.009633 |
734 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
12 |
208 |
0.00152 |
0.009633 |
735 |
NEGATIVE REGULATION OF CELL DIVISION |
6 |
60 |
0.001572 |
0.00991 |
736 |
STEM CELL PROLIFERATION |
6 |
60 |
0.001572 |
0.00991 |
737 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
6 |
60 |
0.001572 |
0.00991 |
738 |
LEUKOCYTE HOMEOSTASIS |
6 |
60 |
0.001572 |
0.00991 |
739 |
REGULATION OF CALCIUM ION TRANSPORT |
12 |
209 |
0.001582 |
0.009963 |
740 |
MITOTIC SPINDLE ASSEMBLY |
5 |
41 |
0.001587 |
0.009967 |
741 |
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS |
5 |
41 |
0.001587 |
0.009967 |